Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial

BACKGROUND: Cigarette smoking is the greatest preventable cause of morbidity and premature mortality in the United States. Approved pharmacological treatments for smoking cessation are marginally effective, underscoring the need for improved pharmacotherapies. A novel approach might use glucagon-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Yammine, Luba, Kosten, Thomas R., Cinciripini, Paul M., Green, Charles E., Meininger, Janet C., Minnix, Jennifer A., Newton, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943874/
https://www.ncbi.nlm.nih.gov/pubmed/29480848
http://dx.doi.org/10.1097/MD.0000000000009567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943874/
https://www.ncbi.nlm.nih.gov/pubmed/29480848
http://dx.doi.org/10.1097/MD.0000000000009567

Ejemplares similares